The editorial was authored by Jacque L. Duncan, MD, professor of ophthalmology and chair of the Department of Ophthalmology, University of California, San Francisco, who did not participate in the PRIMA study.

In a press release issued by Science Corporation, the company described the implant as “consisting of a tiny wireless chip implanted in the retina combined with a pair of special glasses, based on work conducted by Professor Daniel Palanker at Stanford University.”

A total of 38 patients were included in the study. All underwent implantation of the PRIMAretinal prosthetic chip with the goal of restoring vision.